Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wouter S P Jong

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Applied and Environmental Microbiology|July 20, 2014
Decoration of outer membrane vesicles with multiple antigens by using an autotransporter approachMaria H Daleke-Schermerhorn, Tristan Felix, Zora Soprova, et al.
Journal of Extracellular Vesicles|March 15, 2022
A bacterial extracellular vesicle-based intranasal vaccine against SARS-CoV-2 protects against disease and elicits neutralizing antibodies to wild-type and Delta variantsLinglei Jiang, Tom A P Driedonks, Wouter S P Jong, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2022
A bacterial extracellular vesicle-based intranasal vaccine against SARS-CoV-2 protects against disease and elicits neutralizing antibodies to wild-type and Delta variantsLinglei Jiang, Tom A P Driedonks, Wouter S P Jong, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Applied and Environmental Microbiology|July 20, 2014
Decoration of outer membrane vesicles with multiple antigens by using an autotransporter approachMaria H Daleke-Schermerhorn, Tristan Felix, Zora Soprova, et al.
Journal of Extracellular Vesicles|March 15, 2022
A bacterial extracellular vesicle-based intranasal vaccine against SARS-CoV-2 protects against disease and elicits neutralizing antibodies to wild-type and Delta variantsLinglei Jiang, Tom A P Driedonks, Wouter S P Jong, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2022
A bacterial extracellular vesicle-based intranasal vaccine against SARS-CoV-2 protects against disease and elicits neutralizing antibodies to wild-type and Delta variantsLinglei Jiang, Tom A P Driedonks, Wouter S P Jong, et al.
Pageof 4